Elixolife Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-01-2025
- Paid Up Capital ₹ 0.60 M
as on 10-01-2025
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 10-01-2025
- Revenue 17913.40%
(FY 2023)
- Profit 19475.13%
(FY 2023)
- Ebitda -703011.40%
(FY 2023)
- Net Worth 12372.62%
(FY 2023)
- Total Assets 23814.45%
(FY 2023)
About Elixolife Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹3.00 M.
Dipanshu Singhal and Snehlata serve as directors at the Company.
- CIN/LLPIN
U74999UP2020PTC133183
- Company No.
133183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Elixolife Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipanshu Singhal  | Director | 23-Aug-2020 | Current |
| Snehlata | Director | 12-Jan-2022 | Current |
Financial Performance of Elixolife Pharmaceuticals.
Elixolife Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17913.4% increase. The company also saw a substantial improvement in profitability, with a 19475.13% increase in profit. The company's net worth Soared by an impressive increase of 12372.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elixolife Pharmaceuticals?
Unlock access to Elixolife Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 04 May 2023 | ₹3.00 M | Open |
How Many Employees Work at Elixolife Pharmaceuticals?
Elixolife Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elixolife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixolife Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
